Skip to content

Dr. Isabel Lietaert

Active Private limited companyfounded 2007active for 19 yearsOudenaardsesteenweg 106, 8580 AvelgemKBO/BCE: BE 0890.526.217 #3 company by equity in Avelgem, Health and social work sector

Lifetime

18 annual accounts with figures on one time axis
peak of €183,550 in 2008
€156,605▼ 8.7%
peak of €119,612 in 2024
€119,469▼ 0.1%
peak of €891,847 in 2025
€891,847▲ 15.2%
€70,874▼ 62.5%
Board1 name since 2021
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Dividend €1,666Equity from €774,045 to €891,847Debts from €189,168 to €70,874

Key points

from the 2025 annual accounts

Equity

€891,847 ▲ 15.2%

Dr. Isabel Lietaert has made a profit in every financial year since 2008.

Liquidity

13.75 was 4.91 in 2024

Short-term debts fell from €186,941 to €67,862.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

Eight of the last ten came late. The 2019 accounts came in latest, 90 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as Dr. Isabel Lietaert has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for Dr. Isabel Lietaert. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

changes role from manager to director Legal-form conversion: from private limited company (pre-2019) to private limited company · Director discharge: · General meeting of 22-11-2022 · Gazette deed
Capital decrease of €161,232.98 to €18,600 The capital fell from €179,832.98 to €18,600 · General meeting of 20-12-2017 · Gazette deed
Capital increase of €161,232.98 to €179,832.98 The capital rose from €18,600 to €179,832.98 · General meeting of 19-12-2013 · Gazette deed
Incorporation published on 12-07-2007 · Gazette deed
All 28 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Isabel Lietaert Avelgem €962,722 €156,605 92.6% -
DR. LEVECKE Ostend €924,154 €164,797 98.8% -
Dokter Vancanneyt Sofie Bruges €851,629 €164,028 66.0% -
DOKTER ESSEL Wervik €893,105 €173,197 86.6% -
OSTEOPATENPRAKTIJK DE MEYER-AMPE Lokeren €940,876 €145,828 37.3% -
Dokter Dirk HENDRICK Ghent €902,307 €161,929 89.4% -
Medisch Kabinet Dr Sofie Lizin Arendonk €883,490 €143,752 73.2% -

These companies have the same main activity as Dr. Isabel Lietaert: general medical practice (NACE 86210). They are comparable in size and age: total assets between €852,000 and €941,000, founded between 2005 and 2009.

Official details

Source: KBO
Status
Active since 03-07-2007Normal situation
Activity
General medical practiceNACE 86210and 1 other
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €280,000estimated
€962,722▼ 0.1%
Filing
Filed on 31-08-2026
Financials

Insights on Dr. Isabel Lietaert

Dr. Isabel Lietaert files the micro format. That format states no turnover. The gross margin fell from €183,550 in 2008 to €156,605 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Isabel Lietaert

What is the company number of Dr. Isabel Lietaert?
The company number of Dr. Isabel Lietaert is 0890.526.217. The VAT number is the same number with BE in front: BE 0890.526.217.
Where is Dr. Isabel Lietaert based?
The registered office is at Oudenaardsesteenweg 106, 8580 Avelgem.Company details
What does Dr. Isabel Lietaert do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Isabel Lietaert?
Dr. Isabel Lietaert is a private limited company (BV).
When was Dr. Isabel Lietaert founded?
Dr. Isabel Lietaert was founded on 03-07-2007.
Is Dr. Isabel Lietaert still active?
Yes, Dr. Isabel Lietaert is an active enterprise in the KBO register.
What is the turnover of Dr. Isabel Lietaert?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €156,605 and 30 comparable companies (NACE 86210). It probably lies between €230,000 and €350,000.Financials
Is Dr. Isabel Lietaert profitable?
In financial year 2025, Dr. Isabel Lietaert made a profit of €119,469.
Where can I find the annual accounts of Dr. Isabel Lietaert?
Dr. Isabel Lietaert filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Isabel Lietaert due?
Dr. Isabel Lietaert must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.